"chronic disease management"

The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.

'The Pitt' leads Emmy nominations with 25 nods, but the medical drama's bigger achievement is teaching millions of Americans about health an...

A cross-sector goal—making sure every American always knows the date of their next primary care appointment—could be transformative in its i...

A new study suggests inexpensive AI could reshape healthcare’s business model by helping patients use LLMs to manage and improve their healt...

Cadence reached a $1.2 billion valuation by using AI to track seniors’ chronic health conditions and improve their care.

The California Delegated Model offers a blueprint for improving the value of US healthcare.

Hilo Core is a wrist band that tracks blood pressure with optical sensors and reports to an in-depth smartphone app. It’s now launching in t...

As U.S. patient care moves to ambulatory settings, provider tech can't keep up. Five strategies from athenahealth CEO Bob Segert for a bette...

Whether American healthcare reorganizes around prevention will be a test of the quality of its leadership.

AI healthcare panel explores trust, governance, clinician augmentation, cybersecurity, regulation, and medical-grade AI development.